Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mobocertinib is an oral targeted therapy primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations. Its ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：210
Mobocertinib is a targeted therapy drug for non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Its common side effects include diarrhea, rash, stomatitis, na···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：256
The current price of Mobocertinib after medical insurance reimbursement in China is influenced by specific circumstances. If you choose the generic version produced in India, the p···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：227
The current price of Mobocertinib is influenced by purchasing channels, regional policies, and medical insurance coverage. This medication must be used strictly under the guidance ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：243
The usual recommended dose of sotorasib is 960 mg (8 tablets x 120 mg) once daily, taken on an empty stomach at least 1 hour before or 2 hours after eating. Specific usage must be ···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：221
Sotorasib is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, specification, purchasing channel, and···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：312
Lumykras (generic name: Sotorasib) is a prescription targeted therapy drug for non-small cell lung cancer (NSCLC) that targets a specific gene mutation (KRAS G12C). Its price is in···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：256
The price of Sotorasib varies significantly depending on the region, purchasing channel, and specification. For specific prices, please refer to the actual selling prices at hospit···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：223
The side effects of Avatrombopag are generally manageable, with most being mild to moderate in severity. However, risk assessment should be based on individual patient conditions a···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：225
Avatrombopag is an oral medication used to treat thrombocytopenia (low platelet count) associated with chronic liver disease or chemotherapy. Its common side effects include headac···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：216
The price of Avatrombopag varies significantly, typically ranging from a few hundred to several thousand RMB per box. The specific price mainly depends on the version of the drug (···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：255
Lucius Pharmaceuticals Avatrombopag is a prescription medication used to treat thrombocytopenia associated with chronic liver disease or immune thrombocytopenia. The current cost i···【more】
Article source：Captain MedicineRelease date：2026-02-24Recommended：269
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
